ACMJ
Anatolian Current Medical Journal

Anatolian Current Medical Journal (ACMJ) is an unbiased, peer-reviewed, and open access international medical journal. The Journal publishes interesting clinical and experimental research conducted in all fields of medicine, interesting case reports, and clinical images, invited reviews, editorials, letters, comments, and related knowledge.

eISSN: 2718-0115
Creative Commons CC BY-NC-ND 4.0 International License.
EndNote Style

Submit Manuscript

Index
Original Article
Determination of antibiotic resistance rates of Escherichia coli and Klebsiella pneumoniae isolates, which are the causative agents of urinary tract infection in pregnant women
Abstract
Aims: Urinary tract infections are common infections during pregnancy. Infections seen during pregnancy have a spectrum ranging from asymptomatic bacteriuria to cystitis, pyelonephritis and, urosepsis. In this study, it was aimed to determine the antibiotic resistance rates of Escherichia coli (E. coli) and Klebsiella pneumoniae (K. pneumoniae) isolates isolated from urinary cultures of pregnant women who applied to the Ankara Training and Research Hospital. Material and
Methods: The identification and antibiotic susceptibility of E. coli and K. pneumoniae isolates isolated from urinary samples of pregnant women who applied to the Ankara Training and Research Hospital between January 2021 and December 2022 were investigated with VITEK-2 (Biomerioux, France) fully automated system, and the presence of extended-spectrum beta-lactamase (ESBL) was investigated by combined disc diffusion method. The obtained data were analysed retrospectively.
Results: Bacterial growth was detected in 1090 (1.2%) out of a total of 8923 urine samples over a two-year period. 480 (4.4%) of the microbial agents reproducing in urine culture were E. coli and 105 (0.96%) were K. pneumoniae. The rate of extended-spectrum beta-lactamase (ESBL) in E. coli strains was 16.04% (77/480), and the rate of ESBL in K. pneumoniae strains was 20.9% (22/105). Resistance rates of amoxicillin-clavulanic acid, ceftriaxone, phosphomycin, ciprofloxacin, piperacillin-tazobactam, nitrofurantoin, imipenem, meropenem, ertapenem in ESBL negative E. coli strains were 15.9%, 8.82%, 20%, 11.1%, 5.88%, 0%, 0%, 0% and 0%, respectively. Resistance rates of amoxicillin- clavulanic acid, ceftriaxone, phosphomycin, ciprofloxacin, piperacillin-tazobactam, nitrofurantoin, imipenem, meropenem, ertapenem in ESBL positive E. coli strains were determined as 66.5%, 100%, 2.2%, 33.8%, 11.5%, 0%, 0%, 0% and, 0%, respectively. Resistance rates of amoxicillin-clavulanic acid, ceftriaxone, phosphomycin, ciprofloxacin, piperacillin-tazobactam, nitrofurantoin, imipenem, meropenem, ertapenem in ESBL negative K. pneumoniae strains were 53%, 100%, 12.5%, 28.5%, 2.2%, 3.5%, 0%, 0% and, 4.5%, respectively. Resistance rates of amoxicillin-clavulanic acid, ceftriaxone, phosphomycin, nitrofurantoin, ciprofloxacin, piperacillin-tazobactam, imipenem, meropenem, ertapenem in ESBL positive K. pneumoniae strains were 62.5%, 100%, 12.5%, 35%, 28.5%, 22.7%, 0%, 0% and, 4.5%, respectively.
Conclusion: According to the antibiotic susceptibility data in our hospital, phosphomycin or carbapenems may be preferred due to the low resistance rate in the empirical treatment of E. coli-related urinary tract infections in pregnant women. In the treatment of urinary tract infections due to K. pneumoniae, phosphomycin, piperacillin-tazobactam or carbapenems may be preferred due to low resistance rates.

Keywords : Pregnancy, urinary tract infection, Escherichia coli, Klebsiella pneumoniae, extended-spectrum beta-lactamase, antibiotic susceptibility

Download Article


1. Sobel JD, Brown P. Urinary tract infections. In: Bennet JE, DolinR, Blaser MJ, editors. Mandell, Douglas, and Bennett’s Principlesand Practice of Infectious Diseases 9th edi. 2020. p. 962-989 e4.
2. Aşgın N, Eroğlu S, Çakmaklıoğulları EK. Gebelikte üriner sisteminfeksiyonlarının ampirik tedavisinde hangi antibiyotikler ilkseçenek olmalıdır? ANKEM Derg 2018; 32: 94-102
3. İnci M, İnci M, Davarcı M. Gebelikte görülen üriner sistemenfeksiyonları ve tedavisi. Turk Urol Sem 2011; 2: 124-6.
4. Tandogdu Z, Wagenlehner FM. Global epidemiology of urinarytract infections. Curr Opin Infect Dis 2016;29: 73-9.
5. Fasugba O, Gardner A, Mitchell BG, Mnatzaganian G.Ciprofloxacin resistance in community- and hospital-acquiredEscherichia coli urinary tract infections: a systematic review andmeta-analysis of observational studies. BMC Infect Dis 2015; 15:545.
6. Mancini A, Pucciarelli S, Lombardi FE, Barocci S, Pauri P,Lodolini S. Differences between community- and hospital-acquired urinary tract infections in a tertiary care hospital. NewMicrobiol 2020; 43: 17-21.
7. Lee DS, Lee SJ, Choe HS. Community-acquired urinary tractınfection by Escherichia coli in the era of antibiotic resistance.Biomed Res Int 2018; 2018: 7656752.
8. Lee AC, Mullany LC, Koffi AK, et al. Urinary tract infectionsin pregnancy in a rural population of Bangladesh: population-based prevalence, risk factors, etiology, and antibiotic resistance.BMC Pregnancy Childbirth 2019; 20: 1.
9. Rosana Y, Ocviyanti D, Halim M, et al. Urinary tract ınfectionsamong Indonesian pregnant women and ıts susceptibilitypattern. Infect Dis Obstet Gynecol 2020; 2020: 9681632.
10. Ghouri F, Hollywood A, Ryan K. Urinary tract infections andantibiotic use in pregnancy - qualitative analysis of online forumcontent. BMC Pregnancy Childbirth 2019; 19: 289.
11. Genç S, Dündar D. Escherichia coli ve Klebsiella pneumoniaesuşlarında GSBL üretiminin saptanmasında VITEK- 2 otomatizesistemi ile çift disk sinerji testinin karşılaştırılması. TürkMikrobiyol Cem Derg 2015; 45: 36-40.
12. Gülay Z. Antibiyotiklere direnç mekanizmaları ve çözümönerileri: beta-laktamlara ve karbapenemlere direnç. HastaneInfeks Derg 2001; 5: 210-29.
13. European Committee on Antimicrobial Susceptibility Testing(EUCAST). EUCAST Clinical Breakpoint Table Version 10.0,Valid From 2020-01-01. Basel: EUCAST, 2020. http://www.eucast. org/clinical_breakpoints
14. Luu T, Albarillo FS. Asymptomatic bacteriuria: prevalence,diagnosis, management, and current antimicrobial stewardshipımplementations. Am J Med 2022; 135: 236-44.
15. Matuszkiewicz-Rowinska J, Malyszko J, Wieliczko M. Urinarytract infections in pregnancy: old and new unresolved diagnosticand therapeutic problems. Arch Med Sci 2015; 11: 67-77.
16. de Rossi P, Cimerman S, Truzzi JC, et al. Joint report of SBI(Brazilian Society of Infectious Diseases), FEBRASGO (BrazilianFederation of Gynecology and Obstetrics Associations), SBU(Brazilian Society of Urology) and SBPC/ML (Brazilian Societyof Clinical Pathology/Laboratory Medicine): recommendationsfor the clinical management of lower urinary tract infections inpregnant and non-pregnant women. Braz J Infect Dis 2020; 24:110-9.
17. Gupta K, Hooton TM, Naber KG, et al. Infectious DiseasesSociety of America; European Society for Microbiology andInfectious Diseases. International clinical practice guidelines forthe treatment of acute uncomplicated cystitis and pyelonephritisin women: A 2010 update by the Infectious Diseases Societyof America and the European Society for Microbiology andInfectious Diseases. Clin Infect Dis 2011; 52: 103-20.
18. Gur D, Hascelik G, Aydin N, et al. Antimicrobial resistance ingram-negative hospital isolates: results of the Turkish HITIT-2Surveillance Study of 2007. J Chemother 2009; 21: 383-9.
19. Keskin BH, Çalışkan E, Kaya S, Köse E, Şahin İ. Ürinersistem enfeksiyonlarında etken bakteriler ve antibiyotik dirençoranları. Turk Mikrobiyol Cemiy Derg 2021; 51: 254-62.
20. Duran H, Çeken N, Kula Atik T. İdrar kültüründen izole edilenEscherichia coli ve Klebsiella pneumoniae suşlarının antibiyotikdirenç oranları: Dört yıllık analiz. Ankem Derg 2020; 34: 41-7.
21. Avcıoğlu F, Behçet M. üriner sistem enfeksiyonu etkeniEscherichia coli izolatlarının çeşitli antibiyotiklere dirençoranlarının değerlendirilmesi. Turk Mikrobiyol Cemiy Derg2020; 50: 172-7.
22. Bayram Y, Eren H, Berktas M. İdrar örneklerinden izole edilenbakteriyel patojenlerin dağılımı ve GSBL pozitif ve negatifEscherichia coli suşlarının fosfomisin ve diğer antimikrobiyallereduyarlılık paterni. Ankem Derg 2012; 25: 232-36.
23. Tekin A, Deveci Ö, Dal T, et al. Üropatojen Escherichia coliizolatlarına fosfomisin ve bazı antibiyotiklerin in vitro etkinliği.Ankem Derg 2012; 26: 61-8.
Article available in :
Volume 5, Issue 2, 2023
Page : 97-101
https://doi.org/10.38053/acmj.1240882
Article Information
Submitted : 23 Oca 2023
Accepted : 07 Şub 2023
Corresponding Author :

Süheyla Aydoğmuş: Clinic of Obstetrics and Gynaecology, Ankara Training and Research Hospital, University of Health Sciences, Ankara, Turkey

[email protected]
Citation : Aydoğmuş S, Kaya Kılıç E. Determination of antibiotic resistance rates of Escherichia coli and Klebsiella pneumoniae isolates, which are the causative agents of urinary tract infection in pregnant women. Anatolian Curr Med J 2023; 5(2); 97-101.

Read: 642
Cited: 0
Download : 230
_Footer